Pharmaceuticals, Biotechnology and Life Sciences
TORONTO and HAIFA, Israel, May 30, 2025 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone”…
Company to host video webcast at 8:00 a.m. ET on Monday, June 2, 2025WATERTOWN, Mass., May 30, 2025 (GLOBE NEWSWIRE)…
WARREN, N.J., May 30, 2025 (GLOBE NEWSWIRE) — Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today provided stockholders…
Fortress will receive ~$28 million shortly after closing and is eligible for an additional contingent value right (CVR) of up…
TORONTO, May 30, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a…
HANOVER, Md., May 30, 2025 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage pharmaceutical company focused on developing…
CLEVELAND, May 30, 2025 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that Vish Seshadri, Ph.D., Chief Executive…
BERKELEY HEIGHTS, N.J., May 30, 2025 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and…
TORONTO, May 29, 2025 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE:MLZ) (“MediPharm” or the “Company”), a…
WINNIPEG, Manitoba, May 29, 2025 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announces…